Recruiting Depression Studies in Torrance
Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients
The primary objective is to evaluate the efficacy of Ropanicant at two different dosage levels compared to placebo in patients with Major Depressive Disorder (MDD)....
PD, PK, and Safety of ALTO-203 in Patients With MDD
The goal of this clinical trial is to determine the pharmacodynamic effects of ALTO-203 in patients with MDD in a randomized, placebo-controlled, single-dose crossover treatment period. Additionally, ...
About Depression Clinical Trials in Torrance
Depression (major depressive disorder) is a common and serious mood disorder that negatively affects how you feel, think, and handle daily activities. It affects over 280 million people globally. Treatment includes psychotherapy, antidepressant medications, and brain stimulation therapies.
There are currently 2 depression clinical trials recruiting participants in Torrance, CALIFORNIA. These studies are seeking a combined 255 participants. Research is being sponsored by Suven Life Sciences Limited, Alto Neuroscience. Clinical trial participation is free and participants receive study-related medical care at no cost.
Depression Clinical Trials in Torrance — FAQ
Are there depression clinical trials in Torrance?
Yes, there are 2 depression clinical trials currently recruiting in Torrance, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Torrance?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Torrance research site will contact you about next steps.
Are clinical trials in Torrance free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Torrance studies also compensate for your time and travel.
What depression treatments are being tested?
The 2 active trials in Torrance are testing new therapies including novel drugs, biologics, and treatment approaches for depression.
Data updated March 2, 2026 from ClinicalTrials.gov